Author:
Abbasi Fatemeh,Rasoulzadeh Zeinab,Yavari Amirmohammad
Abstract
Abstract
Background
Recurrent Aphthous Stomatitis (RAS) is one of the most common lesions of the oral mucosa. Herbal medicine can be used for the treatment of this disease. The present study aimed to compare the effects of topical application of Sage (Salvizan) and triamcinolone acetonide gels on RAS.
Methods
This double-blind clinical study recruited sixty patients with minor aphthous ulcers. Half of the patients were treated with Salvizan gel, and the other half were treated with oral triamcinolone acetonide gel. The effect of Salvizan topical gel was evaluated and compared with that of oral triamcinolone acetonide gel. Factors such as Pain recovery time, wound healing time, and pain level was evaluated. Data were analyzed by SPSS version 22 using independent t-test, paired t-test, repeated measures ANOVA, and survival analysis, including Kaplan-Meier and Cox regression.
Results
The mean duration of pain recovery was 1.5 days for Salvizan and 2.5 days for triamcinolone acetonide (p < 0.001). Moreover, the duration of wound healing was 3.3 days for Salvizan and 6 days for triamcinolone acetonide (p < 0.001). Patients’ satisfaction from factors such as taste and smell had no significant difference between the two groups.
Conclusion
The results of this study showed that Salvizan gel is very effective in the treatment of RAS. It was significantly better than triamcinolone acetonide in the pain recovery and wound healing. These promising results favor herbal treatments and show that they can be used more commonly for treating diseases such as RAS.
Trial registration
This study was approved by the ethics committee of Isfahan University of Medical Sciences (IR.MUI.RESEARCH.REC.1399.834) on 17/03/2021. It was also registered in the Iranian Registry of Clinical Trials (IRCT20100202003251N7).
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Woo SB, Greenberg MS. Ulcerative, vesicular, and bullous lesion. In: Greenberg MS, Glick M, Ship JA, editors. Burcet’s oral medicine. 12th ed. BC Decker Inc. 2015:73 – 5.
2. Davatchi F, Tehrani BA, Jamshidi AR, Shams DS, Gholami Z, Moradi M, Akhlaghi M, Forouzanfar MH, Barghamdi M, NOUR EE, Samadi F. The prevalence of oral aphthosis in a normal population in Iran:a WHO-ILAR COPCORD study.
3. Darjani A, Joukar F, Naghipour M, Asgharnezhad M, Mansour-Ghanaei F. Lifetime prevalence of recurrent aphthous stomatitis and its related factors in Northern iranian population: the Persian Guilan Cohort Study. Clin Oral Invest. 2021 Feb;25(2):711–8.
4. Krisdapong S, Sheiham A, Tsakos G. Impacts of recurrent aphthous stomatitis on quality of life of 12-and 15-year-old thai children. Qual Life Res. 2012 Feb;21(1):71–6.
5. Hapa A, Aksoy B, Polat M, Aslan U, Atakan N. Does recurrent aphthous stomatitis affect quality of life? A prospective study with 128 patients evaluating different treatment modalities. Journal of dermatological treatment. 2011 Aug 1;22(4):215 – 20.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献